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Tourette Syndrome (TS) is a neurodevelopmental disorder, consisting of multiple
involuntary movements (motor tics) and one or more vocal (phonic) tics. It affects
up to one percent of children worldwide, of whom about one third continue to
experience symptoms into adulthood. The central neural mechanisms of tic generation
are not clearly understood, however recent neuroimaging investigations suggest
impaired cortico-striato-thalamo-cortical activity during motor control. In the current
manuscript, we will tackle the relatively under-investigated role of the peripheral
autonomic nervous system, and its central influences, on tic activity. There is emerging
evidence that both sympathetic and parasympathetic nervous activity influences tic
expression. Pharmacological treatments which act on sympathetic tone are often
helpful: for example, Clonidine (an alpha-2 adrenoreceptor agonist) is often used as
first choice medication for treating TS in children due to its good tolerability profile and
potential usefulness for co-morbid attention-deficit and hyperactivity disorder. Clonidine
suppresses sympathetic activity, reducing the triggering of motor tics. A general elevation
of sympathetic tone is reported in patients with TS compared to healthy people, however
this observationmay reflect transient responses coupled to tic activity. Thus, the presence
of autonomic impairments in patients with TS remains unclear. Effect of autonomic
afferent input to cortico-striato-thalamo-cortical circuit will be discussed schematically.
We additionally review how TS is affected by modulation of central autonomic control
through biofeedback and Vagus Nerve Stimulation (VNS). Biofeedback training can
enable a patient to gain voluntary control over covert physiological responses by making
these responses explicit. Electrodermal biofeedback training to elicit a reduction in
sympathetic tone has a demonstrated association with reduced tic frequency. VNS,
achieved through an implanted device that gives pulsatile electrical stimulation to the
vagus nerve, directly modulates afferent interoceptive signals. The potential efficacy of
biofeedback/VNS in TS and the implications for understanding the underlying neural
mechanisms of tics will be discussed.
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Introduction
Tourette Syndrome (TS) is a neurodevelopmental disorder in
which both neurological and psychological factors underlie the
expression of tics. The syndrome is characterized by multiple
involuntary movements (motor tics) and vocal (phonic) tics that
last more than 1 year. Recent research has shown that TS is
more common than historically estimated, affecting between 0.3
and 0.4% of children worldwide, with some reports indicating
a prevalence of up to one percent of the general population
(Robertson, 2008a,b). TS has been identified and labeled in
all countries and across racial and ethnic groups (Robertson
et al., 2009). TS is more common in children, four times more
common in males, and more prevalent in special educational
needs settings (Comings and Comings, 1990). Perinatal insults
(e.g., birth injuries) and infections may increase the incidence
of TS. The presentation of tics can be diverse and symptoms
fluctuate in severity with occasional remissions. This often
causes problems for assessment and intervention. Starting in
childhood, symptoms usually reach peak level by the age of
11 or 12 years old. Generally symptomology improves with
increase in age (Robertson, 2000; Hassan and Cavanna, 2012).
Most tics are either semi-voluntary or involuntary. Patients
commonly experience uncomfortable premonitory sensations
or urges which are only relieved after the tic action has
been performed (Rajagopal et al., 2013; Crossley et al., 2014).
Jankovic (1997) provides a summary of tic presentations
as: temporarily suppressible; suggestible; increased by stress;
increased with relaxation after stress; decreased by distraction
and concentration; persisting during sleep. A high proportion of
patients (as high as 80%) report premonitory sensations prior
to tic expression (Cohen and Leckman, 1992). A significant
proportion of patients with TS also suffer from comorbid
psychological and psychiatric conditions such as Attention
Deficit Hyperactive Disorder (ADHD), Obsessive Compulsive
Disorder (OCD), depression and impulse control disorders
(Robertson, 2000; Cavanna and Rickards, 2013). Up to 80%
of patients with TS may also suffer from OCD (Eddy and
Cavanna, 2014), highlighting what is thought to be a shared
neural mechanism (dysfunction of caudate nucleus and anterior
cingulate) which will be discussed in the later section.
One of the arguments for implicating the autonomic nervous
system (ANS) in the etiology and maintenance of TS is that,
tic activity is linked to a patient’s psychological and emotional
state (Steinberg et al., 2013a,b), and that sympatholitic drugs such
as Clonidine are often used as the first line medication to treat
patients with TS (Cavanna et al., 2012). Peripheral modulation of
sympathetic nervous system also influences tic expression (Nagai
et al., 2009). In the current manuscript, we explore and discuss
the relatively under-investigated area of the role of autonomic
function on motor activity, especially focusing on interaction
between autonomic activity and tics in patients with TS.
Autonomic Activity and Tic Expression
A relationship between tic frequency and bodily states of
arousal has been observed (Nagai et al., 2009). The tic activity
was observed during experimental induction of relaxation
or arousal using electrodermal biofeedback (Nagai et al.,
2009). Electrodermal activity (EDA) reflects the sympathetic
nervous activity of sweat glands. Patients produced significantly
fewer tics during relaxation biofeedback (decrease in skin
conductivity) compared to the arousal biofeedback (increase
in skin conductivity). TS patients commonly report symptoms,
which are consistent with sympathetic over-activity: increased
heart rate, body temperature, nervousness, and agitation (Shapiro
et al., 1988). Relaxation training is incorporated into some
therapeutic training (Azrin and Peterson, 1988) however the
use of relaxation therapy on its own has been shown not to be
effective in reducing the frequency of tics (Bergin et al., 1988).
Relaxation therapy is often composed of reducing muscular
tension and breathing manipulation, however they usually
lack the monitoring of physiological measures. Thus, main
mechanisms of therapeutic effect are often unclear. Autonomic
modulators are used as a first line medication to reduce symptom
of TS. Clonidine (an alpha-2 adrenergic agonist) which inhibits
release of noradrenalin and suppresses sympathetic activity is
often prescribed for children with TS due to its tolerability of
side effect and also due to caution of long term side effect
with dopaminergic agents (Goetz, 1992). By stimulating alpha-
2 receptors in the vasomotor centers within the brain stem,
the release of norepinephrine is inhibited with an overall effect
in decreasing sympathetic tone (British National Formulary,
1998). Clonidine is also effective in reducing symptoms of
ADHD and OCD, both comorbidities of TS, as well as reducing
irritability, aggressiveness, frustration tolerance, oppositional
behaviors and improving interpersonal functioning (Cohen et al.,
1980). Clinical trials of clonidine report mixed results, with some
studies supporting efficacy (e.g., Leckman et al., 1982, 1991;
Singer et al., 1985; Hedderick et al., 2009) while others have
argued against the effectiveness (e.g., Singer et al., 1985; Goetz
et al., 1987).
Tetrabenazine (Vesicular monoamine transporter: VMAT
inhibitor) has been used as an effective treatment for refractory
TS (Jankovic and Beach, 1997). VMAT2 plays an important
role in transporting norepinephrine and other monoamines in
synaptic vesicles both in the periphery and central nervous
system (Ben-Dor et al., 2007; Eiden and Weihe, 2011; Schafer
et al., 2013). A significant reduction of platelet VMAT2 is
reported in patients with TS indicating, if occurred in the brain,
adaptive mechanisms to dopaminergic over reactivity (Ben-Dor
et al., 2007). The reduction of VMAT2 also indicates impaired
circulation of autonomic agent (norepinephrine).
In an attempt to implicate the parasympathetic nervous
system with TS, Tanner et al. (1982) showed a reduction of motor
tics and an increase of vocal tics after scopolamine injection. The
scopolamine effect was reversed by an injection of physostigmine.
These data suggest that the cholinergic/central parasympathetic
system might be implicated in the pathophysiology of TS and
that cholinergic manipulation may benefit some patients (Tanner
et al., 1982). In addition, the apparent dissociation between
motor and vocal tics raises the possibility that cholinergic
neurotransmissionmight play a role in the differential expression
of these two tic types. Interestingly, the results of clinical
studies conducted in more recent years using hierarchical cluster
analysis and principal component factor analysis techniques
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suggested a separation of tic symptoms, with complex vocal
tics selectively segregating with socially inappropriate behaviors
(Robertson et al., 2008), coprophenomena (Cavanna et al.,
2011), and impulsivity (McGuire et al., 2013). Taken together,
these findings prompt further research aimed at investigating
whether the role of the autonomic system in the differential
expression of motor and vocal tics implies the presence of
multiple underlying mechanisms. Table 1 describes comparison
of studies investigating autonomic functions in patients with
Tourette Syndrome.
Autonomic Abnormalities in Tourette
Syndrome
The extent to which the ANS is dysfunctional in TS remains
uncertain, with research studies producing conflicting and
inconclusive data. The inconsistency to date is influenced by
several factors: differences in experimental protocols; the absence
of healthy control groups in some studies; and the use of
medication in patient groups. The inconsistency could also be
related to the complex clinical profile of TS—with multiple co
morbidities, associated behaviors, and psychopathologies which
makes it difficult to isolate ANS abnormality as a distinct, let
alone causal or maintaining, factor in TS. The next section will
consider some of the empirical literature relating to attempts to
investigate potential autonomic abnormalities in TS patients.
Lake et al. (1977) investigated changes in plasma
noradrenaline concentrations in different positions (standing
and seated) between TS patients and controls (Lake et al., 1977).
No difference found between groups, indicating intact central
mechanisms for orthostatic regulation of sympathetic activity.
In a study by Bock and Goldberger (1985), basal skin resistance
levels and phasic skin resistance responses were measured across
TS patients and a control group during four psychological
tests (the continuous performance test, habituation-sound,
habituation light, and the color-word Stroop task). The patient
group showed less change in electrodermal arousal than controls
during the sound and light habituation tests. The finding that
patients showed less habituation might reflect more persistent
engagement of the reticular activating systems in these patients
(Bock and Goldberger, 1985). Contrary to most research,
Schelkunov et al. (1986) reported slower and more variable
heart rate and reduced blood pressure, suggesting increased
parasympathetic tone.
One investigation of the ANS using non-invasive
measurements of pulse rate and blood pressure during three
tasks: different body positions (supine, standing, and prolonged
standing), cold pressor response test (a cardiovascular test which
involves immersing the hand into an ice water container), and the
Valsalva maneuver (exhalation against a closed airway) showed
no difference in TS patients vs. controls (Goetz et al., 1987).
van Dijk et al. (1992) investigated ANS function in 18 TS
patients and 23 matched controls using four heart rate tests:
variation at rest, during deep breathing, following standing up,
and during a Valsalva maneuver and two blood pressure tests.
The only significant difference between patients and controls was
in the Valsalva test. The patient group showed larger maximum,
but not minimum heart rates compared to the controls (P =
0.03). This was due to the initial heart rate in this group of TS
patients being higher than the control group. This suggests that
there is a possible implication of sympathetic activity on tics,
however this was not be supported by the other five autonomic
tests used in the study.
In their study, Chappell et al. (1994) investigated the effects of
stress caused by the anticipation of a lumbar puncture operation
on plasma adrenocorticotropin (ACTH) and cortisol, urinary
catecholamines, and ratings of anxiety. They concluded that TS
patients may be subject to heightened reactivity of the HPA
axis and associated noradrenergic sympathetic systems. They
found that the TS patients secreted significantly more ACTH in
response to the lumbar puncture and excreted significantly more
norepinephrine than controls when anticipating the operation.
Tics increased with stress, fatigue, emotional trauma, and anxiety
(Chappell et al., 1994). This is in accordance with data from a
small scale pilot study in which emotional arousal was induced in
four children with TS by watching a movie known to engender
specific emotional states (Wood et al., 2003). In this study, tic
severity did not correlate with heart or respiratory rate. Instead
the authors posited that tics, rather than being autonomically
mediated, were induced differentially by certain emotional states.
For example anger and happiness produced lower tic severity in
comparison to sadness and fear, which produced intermediate
severity. The stress response in TS is well summarized in the
recent paper of Martino et al. (2013). The review considers the
involvement of neuroendocrine mechanisms (involving both sex
and stress steroid hormones) to the understanding of TS. The
drugs counteracting the effect of testosterone and possibly the
neuropeptide oxytocin may alter tics (Martino et al., 2013). It
also describes the role of neuroendocrine system (Hypothalamus,
Pituitary gland, and Adrenal cortex: HPA axis) to stress responses
in parallel with autonomic reactions.
In a study looking at cardiovascular and catecholaminergic
activity during mental load, Tulen et al. (1998) pointed to the
functional complexity of the ANS in TS. Their findings again
indicated enhanced cardiovascular activity in the patients, with
higher heart rate and blood pressure during baseline compared
to healthy controls. They found that a significant difference to
controls was not maintained during the mental load task. There
was no significant difference in plasma catecholamines, based on
blood samples taken before and during the task. They concluded
that there was some evidence of increased sympathetic activity in
the TS group and no evidence for alterations in parasympathetic
activity in the patient group (Tulen et al., 1998).
Overall these studies provide variable support for the notion
that both the sympathetic and parasympathetic nervous systems
can influence tic expression and frequency. However, data are
not conclusive, possibly reflecting limitations of experimental
design and the functional complexity of TS, which makes it
difficult to differentiate patients’ autonomic functioning from
healthy controls.
Central Tic Regulation and Autonomic
Nervous System
The precise neural mechanisms of tic generation are still to be
clarified. However, it is generally agreed that tics are caused by
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TABLE 1 | Comparison of studies investigating autonomic functions in patients with Tourette Syndrome.
Study Autonomic and other measurements Patients Results
Lake et al., 1977 Noradrenaline concentration in standing
and seated position
TS patients (n = 33)
Healthy control (n = 22)
No significant difference between the
changes of concentration
Bock and
Goldberger, 1985
Basal skin resistance levels and phasic
skin resistance responses to the following
tests: (1) Continuous Performance Test, (2)
Habituation-sound, (3) Habituation-light,
(4) Color-word test
TS patients (n = 20)
Patients with other chronic illness
(e.g., diabetes, hemophilia) (n = 20)
Patient group showed less change in
arousal (skin resistance level) than controls
during the sound and light habituation
tests. No other group differences
Schelkunov et al.,
1986
Heart rate and blood pressure TS patients (n = 24)
Patients with other conditions
(n = 48): temporal lobe epilepsy
(n = 20), schizophrenia (n = 15),
residual organicity (n = 5), myoclonic
epilepsy (n = 7)
The mean cardiointerval (CI) was
significantly higher in patients with TS
compared with patients with other
conditions
Goetz et al., 1987 Pulse rate and blood pressure
measurements during three tasks: (1)
different body positions (supine, standing,
and prolonged standing), (2) a cold
presser response test (a cardiovascular
test which involves immersing the hand
into an ice water container), and (3) the
Valsalva maneuver (exhalation against a
closed airway)
TS patients (n = 23)
Healthy control (n = 23)
No significant difference between patients
and controls in any autonomic parameters
van Dijk et al., 1992 Heart rate measurement during (1) rest, (2)
deep breathing, (3) standing up, (4)
Valsalva maneuver test, (5) blood pressure
test
TS patients (n = 18)
Healthy control (n = 23)
Higher heart rate in patients with TS in
Valsalva maneuver test. No significant
difference in other autonomic parameters
Chappell et al., 1994 (1) Plasma adrenocorticotropin (ACTH),
(2)cortisol, (3) urinary catecholamines, (4)
anxiety level during lumbar puncture (LP)
stress
TS patients (medication free) n = 13
Healthy control (n = 10)
TS patients secreted significantly more
ACTH than controls in response to the
stress of the lumber puncture. TS patients
excreted more norepinephrine prior to
lumber puncture. Urinary norepinephrine
excretion of TS patients was significantly
correlated with tic severity
Tulen et al., 1998 (1) Plasma catecholamines, (2) Heart rate,
(3) Blood pressure during the Color Word
test, preceded by a baseline measure
TS Patients (n = 9)
Health control (n = 9)
Enhanced cardiovascular activity (both
mean heart rate and mean blood pressure)
in TS patients during sitting/rest than
controls, but no differences plasma
catecholamines. No significant differences
in (1, 2, 3) between groups during the
Color Word test
Wood et al., 2003 Heart rate and respiratory rate measured
while watching a movie to elicit certain
emotional states
TS Patients (n = 4) Tics induced differentially by certain
emotional states. For example anger and
happiness produced lowest tic severity in
comparison to sadness and fear which
produced intermediate severity
Nagai et al., 2009 Tics were monitored during relaxation
(decrease in sympathetic tone) and arousal
(increase in sympathetic tone) biofeedback
TS Patients (n = 15) Tics were significantly lower during
relaxation biofeedback compared to
arousal biofeedback. Tic frequency was
positively correlated arousal level during
arousal biofeedback
a failure of inhibitory action within a cortico-striato-thalamo-
cortical circuit that suppresses premonitory urges for movement
(Mink, 2001; Albin and Mink, 2006). This circuit in frontal
cortex, basal ganglia, and thalamus plays an important role
in coordination and fine motor control. Groups of subcortical
neurons within the basal ganglia translate top-down motor
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FIGURE 1 | Schematic connection of cortico-striato-thalamo-cortical
circuit and associated autonomic centers. The figure describes
cortico-striato-thalamo-cortical circuit (orange box) with excitatory
connection (red line) and inhibitory connection (blue line). Autonomic centers
(purple circle) influences striatum are visceral input from amygdala and insula
(light blue dot line) and parasympathetic influence from subgenial anterior
cingulate (green dot line). Striatum also exert influence to sympathetic
(orange dot line) periaqueductal gray matter.
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control into inhibitory action of the striatum (caudate and
putamen) and globus pallidus on the thalamus, which in turn
sends information back to the cortex. Recent neuroimaging
investigations indeed revealed overall increases in activation
within motor pathways in patients with TS compared to healthy
controls mimicking tic behavior, although activity within anterior
cingulate, caudate, and parietal operculum was significantly
reduced, indicating a lack of inhibitory motor control (Wang
et al., 2011).
Autonomic afferents fibers carry visceral information from
almost all the organs and ascend through the vagus nerve and
spinal cord (Janig, 2006). Such peripheral afferent information
is processed centrally and can create sensations that motivate
behavior according to necessity, e.g., thirst, hunger, pain.
The direct projections of afferent visceral nerves terminate
either at nucleus of the solitary tract (nucleus tractus solitarii,
NTS), parabrachial nucleus or thalamus (ventromedial posterior
thalamus) and information is further carried at basal ganglia and
cortical levels (Critchley and Harrison, 2013). The influence of
autonomic activity on motor function is not clearly understood.
However, it is worth noting that within cortico-striato-thalamo
cortical circuits, the striatum receives afferent information
directly from both right and left amygdala and viscerosensory
insular cortex. It is also derived by cortical centers implicated in
parasympathetic regulation for example the subgenual anterior
cingulate (Critchley and Harrison, 2013). However, autonomic
outputs from the striatum appear dominated by sympathetic
drive linked to motor function (see Figure 1). We discussed in
the previous section that autonomic dysfunction in patients with
TS is difficult to conclude unlike some neurological condition
(sudden unexpected death in epilepsy: SUDEP) with which
autonomic dysfunction can be fatal. It is likely that emotional
disturbance influences striatal activity through visceral input
of amygdala and insular (Figure 1). Impairment of inhibitory
mechanisms within cortico-striato-thalamo cortical circuit may
thus underlie uncontrollable motor tics in TS.
Autonomic Modulation as a Treatment
of TS
Modulation of the autonomic nervous system can be achieved
through vagus nerve stimulation (VNS) and autonomic
biofeedback. VNS uses an implanted device for pulsatile
electrical stimulation of the vagus nerve, directly modulates
afferent interoceptive signals. Two small scale studies have
applied VNS to TS (Diamond et al., 2006; Sperling et al., 2008).
In the single case report by Diamond et al. (2006) an implanted
vagal nerve stimulator led to improvements on the total tic
score and the motor and phonic tic frequency. One study
also reported improvement in tic severity and clinical ratings
following VNS, however the effectiveness of this treatment
needs to be confirmed by systematic clinical trials with an
appropriate sample size (Sperling et al., 2008). Nagai et al.
(2009) investigated the efficacy of electrodermal biofeedback on
tic activity in patients with TS. Biofeedback is a non-invasive
psychophysiological intervention, which can be used to directly
modulate physiological responses. It enables patients to perceive
their bodily signals through visual and auditory feedback and
eventually to learn to control their bodily state of arousal.
The investigation using electrodermal biofeedback training,
targeting sympathetic arousal level, have found that a reduction
in sympathetic tone was associated with a reduction in tic
frequency (Nagai et al., 2009). However, contrary to the findings
in a basic study where patients showed significantly less tic
activity during 5min of relaxation biofeedback, interpretation
of the clinical trial was not straightforward that patients found
it difficult to maintain longer period of relaxation biofeedback
as a treatment due to concomitantly occurring tics (Nagai et al.,
2014).
Conclusion
There is a paucity of research regarding autonomic influences on
tics. The central (efferent) influence of tic activity on peripheral
autonomic activity remains unclear due to inconclusive results
of the different studies, however it is likely that afferent visceral
input influences cortico-striato-thalamo-cortical circuit through
enhanced dysfunction of inhibitory mechanisms of striatum.
Understanding the relationship between peripheral autonomic
activity and central motor activity is important for elucidating
how emotional disturbance affect tic activity (visceral afferent
input as a trigger of tics) and for investigating how peripheral
autonomic modulation may contribute to the treatment of TS.
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